TY - JOUR
T1 - The bench is closer to the bedside than we think
T2 - Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials
AU - Yarborough, Mark
AU - Bredenoord, Annelien
AU - D’Abramo, Flavio
AU - Joyce, Nanette C.
AU - Kimmelman, Jonathan
AU - Ogbogu, Ubaka
AU - Sena, Emily
AU - Strech, Daniel
AU - Dirnagl, Ulrich
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Millions of people worldwide currently suffer from serious neurological diseases and injuries for which there are few, and often no, effective treatments. The paucity of effective interventions is, no doubt, due in large part to the complexity of the disorders, as well as our currently limited understanding of their pathophysiology. The bleak picture for patients, however, is also attributable to avoidable impediments stemming from quality concerns in preclinical research that often escape detection by research regulation efforts. In our essay, we connect the dots between these concerns about the quality of preclinical research and their potential ethical impact on the patients who volunteer for early trials of interventions informed by it. We do so in hopes that a greater appreciation among preclinical researchers of these serious ethical consequences can lead to a greater commitment within the research community to adopt widely available tools and measures that can help to improve the quality of research.
AB - Millions of people worldwide currently suffer from serious neurological diseases and injuries for which there are few, and often no, effective treatments. The paucity of effective interventions is, no doubt, due in large part to the complexity of the disorders, as well as our currently limited understanding of their pathophysiology. The bleak picture for patients, however, is also attributable to avoidable impediments stemming from quality concerns in preclinical research that often escape detection by research regulation efforts. In our essay, we connect the dots between these concerns about the quality of preclinical research and their potential ethical impact on the patients who volunteer for early trials of interventions informed by it. We do so in hopes that a greater appreciation among preclinical researchers of these serious ethical consequences can lead to a greater commitment within the research community to adopt widely available tools and measures that can help to improve the quality of research.
UR - http://www.scopus.com/inward/record.url?scp=85049360559&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049360559&partnerID=8YFLogxK
U2 - 10.1371/journal.pbio.2006343
DO - 10.1371/journal.pbio.2006343
M3 - Article
C2 - 29874243
AN - SCOPUS:85049360559
VL - 16
JO - PLoS Biology
JF - PLoS Biology
SN - 1544-9173
IS - 6
M1 - e2006343
ER -